Leidos Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LDOS research report →
Range $132 – $245
Price Chart
About the company
Leidos Holdings, Inc. , along with its various subsidiaries, delivers a broad spectrum of services and innovative solutions across key markets: defense, intelligence, civil government, and health. The company operates both domestically within the United States and on an international scale.
- CEO
- Thomas A. Bell
- IPO
- 2006
- Employees
- 50,000
- HQ
- Reston, VA, US
Get TickerSpark's AI analysis on LDOS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.91B
- P/E
- 10.86
- Fwd P/E
- 9.67
- PEG
- 2.80
- P/S
- 0.84
- P/B
- 2.93
- EV/EBITDA
- 8.77
- Div Yield
- 1.41%
- Gross Margin
- 17.26%
- Op Margin
- 11.42%
- Net Margin
- 8.03%
- ROE
- 28.04%
- ROIC
- 15.07%
Latest fiscal year · YoY change
- Revenue
- $17.17B+3.1%
- Gross Profit
- $3.03B+8.4%
- Op Income
- $2.11B
- Net Income
- $1.46B+16.1%
- EPS
- $11.22+19.9%
- OCF Growth
- +25.7%
- FCF Growth
- +30.7%
- 52W High
- $205.00
- 52W Low
- $98.86
- 50D MA
- $128.55
- 200D MA
- $137.16
- Beta
- 0.54
- RSI (14)
- 34
- Avg Volume
- 1.14M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Leidos posted a strong Q3 with revenue, margins, EPS and cash flow all improving, while raising guidance again on better cash generation and continued business momentum.· November 3, 2026
- Revenue was $4.63 billion, up 4% overall and 1% organically; adjusted EBITDA margin was 13.9% and non-GAAP diluted EPS rose 19% to $3.62.
- Free cash flow was $476 million in the quarter, bringing year-to-date cash flow to $1.5 billion and ahead of the company’s original full-year target.
- Bookings were strong at $5.5 billion with a 1.2x book-to-bill; Defense book-to-bill was 1.9 this quarter and 2.0 year-to-date.
- Management said customer procurement activity is improving, with a $49.6 billion backlog and $11.1 billion of funded backlog, up 22% year over year.
- Leidos raised 2026 guidance again after the SES divestiture and cash outperformance, while keeping adjusted EBITDA guidance in the mid-13s.
Leidos reported third-quarter revenue of $4.63 billion, up 4% year over year and 1% organically. Adjusted EBITDA was $644 million, for a 13.9% margin, up 10 basis points sequentially and year over year. Non-GAAP diluted EPS was $3.62, up 19% year over year. Cash from operations was $523 million and free cash flow was $476 million; free cash flow yield was 105% for the quarter and 121% over the trailing 12 months. Net awards were $5.5 billion and book-to-bill was 1.2x. Backlog reached $49.6 billion, up 4% year over year, and funded backlog was $11.1 billion, up 22% year over year and 8% sequentially. Management said 2026 guidance was enhanced again; the update reflects the SES divestiture, Q3 results and updated outlook. They said fourth-quarter revenue is expected to be near Q3 levels, adjusted EBITDA guidance remains in the mid-13s, operating cash flow guidance is effectively raised by $100 million, and the guidance assumes a continuing resolution through year-end.
Tom Bell framed the quarter as evidence that NorthStar 2030 is working, citing portfolio reshaping, outcome-based offerings, and investment in repeatable technologies. He highlighted Defense Tech, Energy, Health, and Intelligence as areas where Leidos is building durable growth platforms, including commercial cyber and AI products like Parcata and new offerings such as MySTR. His tone was upbeat and confident, but measured on the VBA MDE recompete, where he emphasized Leidos is well positioned while acknowledging the process is still early and uncertain.
Chris Cage emphasized the quality of the quarter’s financial performance, including $4.63 billion of revenue, $644 million of adjusted EBITDA, a 13.9% margin, $3.62 of non-GAAP EPS, $523 million of operating cash flow and $476 million of free cash flow. He noted the non-GAAP effective tax rate was 15.1% in Q3, aided by tax optimization and a revised R&D tax credit approach accepted by the IRS, though the impact should be more modest later. He also outlined capital deployment: $500 million of share repurchases, a $0.02 increase in the quarterly dividend, higher CapEx in Q3 and even more in Q4 mainly for Defense Tech production capacity, plus leverage of 2.5x with $6 billion of debt and $630 million of cash. On guidance, he said SES contributed about $200 million of Q4 revenue and about $0.12 of EPS, that the divestiture effectively raises operating cash flow guidance by $100 million, and that adjusted EBITDA guidance stays in the mid-13s.
Analysts pressed management on bookings, Defense Tech ramp timing, the VBA rebid, Health margins, and whether 2027 could be a bottom-line growth year. Management said procurement activity is improving, book-to-bill has climbed from 0.8 in Q1 to 1.1 in Q2 and 1.2 in Q3, and that backlog and the 12-month pipeline are both growing; they also cited OTA activity, including 212 OTA contracts and new cyber awards. On VBA, management said the draft RFP likely favors incumbents and could allow Leidos to retain or even improve work share, but they refused to bound the outcome because the final RFP is not out yet. For 2027, Chris Cage said it is not a bottom-line growth year in the near term because of VBA timing, but he remains bullish on growth beyond that as Defense, Energy and cyber continue to scale.
The call’s bull case is that Leidos is converting strategy into real operating momentum: revenue, EPS, margins, cash flow and bookings all improved, while backlog and the 12-month pipeline are expanding. Management believes Defense Tech, Energy, cyber and Homeland can all support above-market growth over time, and they repeatedly described the company’s portfolio as undervalued relative to its parts.
The main risk is the ongoing VBA disability exam recompete, which management said could affect Health revenue, margins and overall earnings timing into 2027. They also flagged delayed procurement decisions, pressure on cost-plus revenue from indirect efficiencies, and a full-quarter impact from the VBA contract changes in Q4. In Defense Tech, near-term profitability is still being weighed down by CapEx and production investments before the higher-margin ramp fully shows through.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.2%
- Shares Outstanding
- 122.00M
- Float Shares
- 121.08M
of shares held by institutions
803 13F filers
Buy/sell ratio 0.75. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for LDOS, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Alan ArmstrongSenate | Sell | Mar 27, 26 | Filing → |
| Keith SelfHouse | Sell | Oct 7, 25 | Filing → |
| Gerald E. ConnollyHouse · VA11 | Sell | May 13, 25 | Filing → |
| Gerald E. ConnollyHouse · VA11 | Sell | Feb 5, 25 | Filing → |
| Gerald E. ConnollyHouse · VA11 | Sell | Oct 10, 24 | Filing → |
| Gerald E. ConnollyHouse · VA11 | Sell | Jul 2, 24 | Filing → |
| Gerald E. ConnollyHouse · VA11 | Sell | Mar 18, 24 | Filing → |
| Gerald E. ConnollyHouse · VA11 | Sell | Nov 13, 23 | Filing → |
| Gerald E. ConnollyHouse · VA11 | Sell | Aug 15, 23 | Filing → |
| Gerald E. ConnollyHouse · VA11 | Sell | Mar 29, 23 | Filing → |
| Gerald E. ConnollyHouse · VA11 | Sell | Dec 6, 22 | Filing → |
| Gerald E. ConnollyHouse · VA11 | Sell | Aug 30, 22 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 20, 22 | Filing → |
| Gerald E. ConnollyHouse · VA11 | Sell | Dec 9, 21 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 14.94M | ▼ 59.81K |
| Blackrock, Inc. | 9.77M | ▼ 180.73K |
| Vanguard Capital Management LLC | 8.20M | ▼ 12.72K |
| State Street Corp | 5.99M | ▼ 285.24K |
| Vanguard Portfolio Management LLC | 5.17M | ▼ 201.17K |
| Jpmorgan Chase & Co | 3.85M | ▲ 18.03K |
| Geode Capital Management, LLC | 3.76M | ▲ 89.58K |
| First Trust Advisors LP | 3.09M | ▲ 315.20K |
| Invesco Ltd. | 2.86M | ▼ 274.19K |
| Dimensional Fund Advisors LP | 2.30M | ▲ 177.01K |
| Van Eck Associates Corp | 2.07M | ▲ 49.73K |
| Massachusetts Financial Services Co | 1.96M | ▼ 47.22K |
Held by 1,143 ETFs
Biggest fund positions in LDOS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 17, 26 | Stevens Roy E | other | 6,611 |
| Nov 17, 26 | Stevens Roy E | other | 8,746 |
| Nov 17, 26 | Stevens Roy E | other | 13,070 |
| Nov 17, 26 | Stevens Roy E | sell | 2,287 |
| Nov 17, 26 | Stevens Roy E | other | 8,746 |
| Nov 17, 26 | Stevens Roy E | other | 6,611 |
| Oct 7, 26 | KRAEMER HARRY M JANSEN JR | other | 297.226 |
| Oct 1, 26 | McElfresh Jeffery S. | other | 0 |
| Sep 30, 26 | Antal Daniel J. | other | 4.711 |
| Sep 30, 26 | Cage Christopher R | other | 92.778 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our LDOS coverage
Recent articles, reports, and earnings notes.

WW3, Revealed: Every Stock Bryan Perry Is Teasing in Hi-Tech Trader
Bryan Perry's Hi-Tech Trader is promoting The Empire Strikes Back, a three-stock space-race pitch. We identify the companies and test its WW3 claims.

REDLattice's De-SPAC: What Investors Need to Know
REDLattice is a U.S.-based defense tech company going public through a merger with Bold Eagle Acquisition Corp. (NASDAQ: BEAG), with closing expected around year-end 2026. The setup offers real revenue and backlog, but shareholders should watch redemption risk, dilution, and whether the financing package holds together.

Government IT Services Stocks That Drive Modernization: 7 Picks (Nov. 2026)
A countdown spans government cloud, cyber, modernization, mission systems, and managed services, featuring Maximus, KBR, CACI, Leidos, and Booz Allen.
Want a deeper read on LDOS?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Can MRADR Deployment Strengthen Leidos' Defense Technology Growth?
zacks.com · Nov 19
Leidos building low-signature air defense for Marines
prnewswire.com · Nov 18
Leidos continuing support for NASA flight hardware, logistics
prnewswire.com · Nov 17
Here's Why Leidos (LDOS) is a Strong Growth Stock
zacks.com · Nov 13
Leidos Q3: Mission Intact
seekingalpha.com · Nov 13
Bringing Women's Preventive Care Closer to Home
accessnewswire.com · Nov 12
Leidos Launches Agentic AI Platform To Speed Response to Cyber Threats
accessnewswire.com · Nov 10
Why Leidos (LDOS) is a Top Momentum Stock for the Long-Term
zacks.com · Nov 6
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.